Brief: Ligand Pharmaceuticals Names Director Todd C. Davis As CEO

Ligand Pharmaceuticals Incorporated

05/12/2022 12:07

Dec 5 (Reuters) - Ligand Pharmaceuticals Inc  LGND.O :
    * LIGAND PHARMACEUTICALS NAMES DIRECTOR TODD C. DAVIS AS CEO
    * LIGAND PHARMACEUTICALS INC - JOHN HIGGINS RETIRES AS CEO
AND
WILL RESIGN FROM LIGAND BOARD OF DIRECTORS
    * LIGAND PHARMACEUTICALS INC - HIGGINS WILL CONTINUE TO
SERVE AS
CHAIRMAN OF OMNIAB

Source text for Eikon:  ID:nBw70v2QBa 
Further company coverage:  LGND.O